Proof of principle phase 1b / randomised phase 2 study of afatinib penetration into cerebral
metastases for patients undergoing neurosurgical resection, both with and without prior
low-dose, targeted radiotherapy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Collaborators:
Boehringer Ingelheim Cancer Research UK The Brain Tumour Charity University of Cambridge